Supplementary Material from Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank
Knuppel A., Fensom GK., Watts EL., Gunter MJ., Murphy N., Papier K., Perez-Cornago A., Schmidt JA., Smith Byrne K., Travis RC., Key TJ.
<p>Supplementary Tables S1-3 and Figures S1-3. Table S1: Median, interquartile range (IQR), minimum (Min.) and maximum (max.) of follow-up time by cancer site. Table S2: Hazard ratios (HRs) and 95% confidence intervals (CIs) of cancer risk according to circulating insulin-like growth factor-I concentrations. Table S3: Hazard ratios (HRs) and 95% confidence intervals (CIs) of cancer risk according to circulating insulin-like growth factor-I concentrations stratified by follow-up time, sex and age-group. Figure S1: Flow diagram for reaching the analytical sample. Figure S2: Hazard ratios (HRs) and 95% confidence intervals (CIs) for cancer risk per 5 nmol/l higher insulin-like growth factor-I concentration by cancer site and sex. Figure S3: Hazard ratios (HRs) and 95% confidence intervals (CIs) for cancer risk per 5 nmol/l higher insulin-like growth factor-I concentration by cancer site and age (<55, {greater than or equal to}55 years) at biomarker assessment.</p>